Journals / Fırat Üniversitesi Sağlık Bilimleri Tıp Dergisi / 2019 / Cilt: 33 - Sayı: 2

Diagnosis and Treatment of Axial Spondyloarthritis

Aksiyel Spondilartritlerin Tanı ve Tedavisi

Pages
119–124
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Non-steroidal anti-inflammatory drugs, sulfasalazine, and biological treatment agents are used in medical treatment, respectively.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Spondyloarthritis (SpA) group, which causes similar clinical findings and is treated similarly, is evaluated in two subgroups as axial and peripheral according to clinical characteristics.
📊
Key Findings & Data:The search for sacroiliitis by direct radiography or MRI and HLA-B27 are other diagnostic procedures.
💡
Conclusion & Impact:Non-steroidal anti-inflammatory drugs, sulfasalazine, and biological treatment agents are used in medical treatment, respectively.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Spondyloarthritis (SpA) group, which causes similar clinical findings and is treated similarly, is evaluated in two subgroups as axial and peripheral according to clinical characteristics. It is named as radiographic axial SpA if sacroiliitis is shown on X-ray, and if sacroiliitis detected on magnetic resonance imaging (MRI) but X-ray normal; it is considered to be a non-radiographic axial SpA. Diagnosis is psoriatic arthritis (radiographic or non-radiographic) if psoriasis associated with SpA; enteropathic arthritis (radiographic or non-radiographic) with inflammatory bowel disease; It is considered as reactive if occurred after an infection. If there is no comorbid disease and radiographically proven sacroiliitis, it is named as ankylosing spondylitis (AS). The most basic diagnostic tool of axial SpA is the history of inflammatory back pain. The search for sacroiliitis by direct radiography or MRI and HLA-B27 are other diagnostic procedures. The treatment of AS and axial SpA begins with physical exercise and prevention of exposure to tobacco products. Non-steroidal anti-inflammatory drugs, sulfasalazine, and biological treatment agents are used in medical treatment, respectively.

Özet

Benzer klinik bulgulara yol açan ve benzer şekilde tedavi edilen spondilartrit (SpA) grubuhastalıklar, klinik özelliklerine göre, aksiyel ve periferal olarak iki alt grupta değerlendirilir. AksiyelSpA’da, sakroiliit direk grafide gösterilmiş ise radyografik aksiyel SpA; direk grafi normal ikenmanyetik rezonans görüntüleme (MRG)’de sakroiliit gösterildi ise non-radyografik aksiyel SpA (nraxSpA)olarak kabul edilir. SpA ile birlikte psöriazis varsa tanı psöriatik artrit (radyografik veya nonradyografik);inflamatuar barsak hastalığı ile birlikte ise enteropatik artrit (radyografik veya nonradyografik);enfeksiyonlar sonrası oluştu ise reaktif artrit olarak kabul edilir. Eşlik eden hastalığıyok ve SpA radyografik ise ankilozan spondilit (AS) olarak adlandırılmaktadır.AS ve aksiyel SpA’nın en temel tanısal aracı bel ağrısının inflamatuar karakterde olmasıdır. Direkgrafi ve MRG ile sakroiliitin aranması ve HLA-B27 testi diğer tanısal işlemlerdir. AS ve aksiyelSpA’nın tedavisi tütün ürünlerine maruziyetin engellenmesi ve fizik egzersiz ile başlar. Medikaltedavide ise sırasıyla non-steroidal anti-inflamatuarlar, sülfasalazin ve biyolojik tedavi ajanlarıkullanılmaktadır.

🔖

Cite This Article

ÖZ, B., KARATAŞ, A., DÖNDER, E., KOCA, S. S., AKAR, Z. A. (2022). Diagnosis and Treatment of Axial Spondyloarthritis. Fırat Üniversitesi Sağlık Bilimleri Tıp Dergisi, Cilt: 33 - Sayı: 2, 119–124. https://ajindex.com/articles/514508

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Taurog JD, Chhabra A, Colbert RA. Ankylosing Spondylitis and Axial Spondyloarthritis. N Engl J Med 2016; 374: 2563-2574.
  2. Raychaudhuri SP, Deodhar A. The classification and diagnostic criteria of ankylosing spondylitis. J Autoimmun 2014; 48: 128-33. Mease PJ. Fibromyalgia, a missed comorbidity in spondyloarthritis: prevalence and impact on assessment and treatment. Curr Opin Rheumatol 2017; 29: 304-310.
  3. Slobodin G, Lidar M, Eshed I. Clinical and imaging mimickers of axial spondyloarthritis. Semin Arthritis Rheum 2017; 47: 361-368.
  4. Golder V, Schachna L. Ankylosing spondylitis: an update. Aust Fam Physician 2013; 42: 780-784.
  5. Sieper J, Braun J, Dougados M, Baeten D. Axial spondyloarthritis. Nat Rev Dis Primers 2015; 1: 15013. Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet 2017; 390: 73-84. Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection. Ann Rheum Dis 2009; 68: 777-783.
  6. Akar S, Igci YZ, Sari I, et al. Do major histocompatibility complex tag single nucleotide polymorphisms accurately identify HLA-B27 in the Turkish population? Int J Rheum Dis 2017; 20: 2035-2039.
  7. Goie The HS, Steven MM, van der Linden SM, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Br J Rheumatol 1985; 24: 242-249. van der Heijde D, Ramiro S, Landewé R, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 2017; 76: 978-991.
  8. Wendling D, Lukas C, Prati C, et al. 2018 update of French Society for Rheumatology (SFR) recommendations about the everyday management of patients with spondyloarthritis. Joint Bone Spine 2018; 85: 275-284.
  9. Can M, Aydın SZ, Niğdelioğlu A, Atagündüz P, Direskeneli H. Conventional DMARD therapy (methotrexate-sulphasalazine) may decrease the requirement of biologics in routine practice of ankylosing spondylitis patients: a real-life experience. Int J Rheum Dis 2012; 15: 526-530.
  10. Karadağ Ö, Kaşifoğlu T, Özer B, et al. Viral hepatitis screening guideline before biological drug use in rheumatic patients. Eur J Rheumatol 2016; 3: 25-28.
  11. Tanrıöver MD, Akar S, Türkçapar N, et al. Vaccination recommendations for adult patients with rheumatic diseases. Eur J Rheumatol 2016; 3: 29-3